AusBiotech

Thriving medtech community celebrated at record-breaking AusMedtech 2022 May 26, 2022

Demonstrating the buoyancy and growth of the sector, AusBiotech recorded its largest-ever face-to-face AusMedtech conference this week as the Australian medtech sector reunited and celebrated its achievements.

Brandon Capital backs New Zealand immunotherapy start-up May 25, 2022

Brandon Capital has partnered with another investor to inject NZ$15.25 million into the University of Auckland spin-out TamoRx.

Anteris Technologies expands its medical advisory board May 25, 2022

Anteris Technologies (ASX:AVR) has announced the appointment of Associate Professor Dion Stub of the Alfred Hospital and Monash University to its Australian medical advisory board.

Archer Materials secures Australian patent for quantum computing chip May 24, 2022

Archer Materials (ASX:AXE) has secured an Australian patent for its 12CQ quantum computing chip technology.

New clinical trial to test cancer drug in motor neuron disease May 24, 2022

PharmAust (ASX:PAA) is launching a Phase 1 clinical trial of monepantel for the treatment of motor neuron disease or Amyotrophic Lateral Sclerosis.

AusBiotech welcomes incoming federal government May 24, 2022

AusBiotech welcomes the 31st Australian government and extends its congratulations to incoming ministers and elected members of parliament.

New government starts work on key election commitments May 24, 2022

Labor's interim ministry has started work on key election commitments including its planned Budget and the major boost for medical manufacturing.

4DMedical appoints director to executive position May 24, 2022

Respiratory imaging technology company 4DMedical (ASX:4DX) has announced that director John Livingston has been appointed to an executive position with the company.

Living Cell Technologies announces new agreement to use AI in trial May 24, 2022

Living Cell Technologies (ASX:LCT) says artificial intelligence will be applied to its research into Parkinson’s disease under a new agreement with OptiCellAI.

MCIA releases roadmap to growth for the Australian medicinal cannabis industry May 24, 2022

Medicinal Cannabis Industry Australia has released a roadmap it hopes will provide the vision and way forward for the sector's growth in Australia.

AnteoTech's updated COVID-19 RAT receives regulatory approval in Europe May 19, 2022

AnteoTech (ASX:ADO) has registered an updated EuGeni COVID-19 Rapid Antigen Test in Europe under the In Vitro Diagnostic Directive 98/79/EC Regulations.

FDA confirms a diagnostic method for Medibio’s final depression validation trial May 19, 2022

Medibio (ASX:MEB) has announced that a DSM-V 1 diagnosis will be included as a primary comparator for the purposes of assessing the efficacy of its depression algorithms, MEB-001.

Most Read

New Stories

Thriving medtech community celebrated at record-breaking AusMedtech 2022

Brandon Capital backs New Zealand immunotherapy start-up

Anteris Technologies expands its medical advisory board

Archer Materials secures Australian patent for quantum computing chip

New clinical trial to test cancer drug in motor neuron disease

AusBiotech welcomes incoming federal government

New government starts work on key election commitments

Sign In